Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

BACKGROUND: The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. METHODS: We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Taguchi, Satoru, Buti, Sebastiano, Fukuhara, Hiroshi, Otsuka, Masafumi, Bersanelli, Melissa, Morikawa, Teppei, Miyazaki, Hideyo, Nakagawa, Tohru, Fujimura, Tetsuya, Kume, Haruki, Igawa, Yasuhiko, Homma, Yukio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328261/
https://ncbi.nlm.nih.gov/pubmed/28241027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0172341
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg